Quadrant Biosciences Inc — Regulation A 1-A
Quadrant Biosciences Inc of SYRACUSE, NY filed a Regulation A 1-A with the SEC on 2020-02-14. Aggregate offering: $15.0M (Tier 2). Industry: Other.
Offering
- Filed: 2020-02-14
- Form: 1-A
- Accession: 0001104659-20-021527
- Tier: Tier 2
- Total aggregate offering: $15.0M
- Issuer portion: $15.0M
- Price per security: $3.0000
- Securities offered: Equity (common or preferred stock)
- Underwriter: North Capital Private Securities Corporation
- Broker-dealer CRD: 154559
- Audit status: Audited
- Auditor: Dannible & McKee, LLP
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001651239
- Organized in: DE
- Incorporated: 2015
- Address: 505 IRVING AVENUE, SYRACUSE, NY, 13210
- Phone: 315-614-2325
- Employees: 42 full-time
Financial snapshot (as filed)
- Total assets: $9.8M
- Cash & equivalents: $3.1M
- Total liabilities: $5.9M
- Stockholder equity: $3.9M
- Revenues: $343K
- Net income: $-4.8M
People (1)
| Name | Role | Location |
|---|
| Jamie Ostrow | Signer | TRENTON, NJ |
Other Reg A filings by this issuer (4)
More